Review article| Volume 132, ISSUE 1, P16-24, July 1998

Pulmonary hypertension and inflammation

  • Rubin M. Tuder
    Reprint requests: Rubin M. Tuder, MD, Associate Professor of Pathology, University of Colorado Health Sciences Center, 4200 East Ninth Ave., Denver, CO 80262.
    Pulmonary Hypertension Center and the Department of Medicine, Division of Respiratory and Critical Care Medicine, and the Department of Pathology, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Search for articles by this author
  • Norbert F. Voelkel
    Pulmonary Hypertension Center and the Department of Medicine, Division of Respiratory and Critical Care Medicine, and the Department of Pathology, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.


      ACE (angiotensin-converting enzyme), All (angiotensin II), CREST (calcinosis Raynaud's phenomenon esophageal involvement sclerodactyly telangiectasia), ET-1 (endothelin-1), 5-LO (5-lipoxygenase), FGF (fibroblast growth factor), FLAP (5-LO activating protein), IGF-1 (insulin-like growth factor), IL-1 (interleukin-1), MCT (monocrotaline), PAF (platelet-activating factor), PDGF (platelet-derived growth factor), PPH (primary pulmonary hypertension), TF (tissue factor TGF-β transforming growth factor-β), VEGF (vascular endothelial growth factor), VSMC (vascular smooth muscle cell)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Voelkel NF
        • Tuder RM
        • Weir EK
        Pathophysiology of primary pulmonary hypertension: from physiology to molecular mechanisms.
        in: Rubin LJ Rich S Primary pulmonary hypertension. Marcel Dekker, New York1997: 83-129
        • Lee S-L
        • Wang WW
        • Lanzillo JJ
        • Fanburg BL
        Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture.
        Am J Physiol. 1994; 266: L46-L52
        • Voelkel NF
        • Tuder RM
        Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension.
        Eur Respir J. 1995; 8: 2129-2138
        • Fanburg BL
        • Lee S-L
        A new role for an old molecule: serotonin as a mitogen.
        Am J Physiol. 1997; 272: L795-L806
        • Heath D
        • Yacoub M
        Lung mast cells in plexogenic pulmonary arteriopathy.
        J Clin Pathol. 1991; 44: 1003-1006
        • Blair RJ
        • Meng H
        • Marchese MJ
        • Ren S
        • Schwartz LB
        • Tommesen MG
        • et al.
        Human mast cells stimulate vascular tube formation.
        J Clin Invest. 1997; 99: 2691-2700
        • Caslin AW
        • Heath D
        • Madden B
        • Yacoub M
        • Gosney JR
        • Smith P
        • et al.
        The histopathology of 36 cases of plexogenic pulmonary arteriopathy.
        Histopathology. 1990; 16: 9-19
        • Tuder RM
        • Groves B
        • Badesch DB
        • Voelkel NF
        Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
        Am J Pathol. 1994; 144: 275-285
        • Cool CD
        • Kennedy D
        • Voelkel NF
        • Tuder RM
        Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection.
        Hum Pathol. 1997; 28: 434-442
        • Kuwara K
        • Ogawa S
        • Matsumoto M
        • Koga S
        • Clauss M
        • Pinsky DJ
        • et al.
        Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells.
        Med Sci. 1995; 92: 4606-4610
        • Ross R
        The pathogenesis of atherosclerosis: a perspective for the 1990s.
        Nature. 1993; 362: 801-809
        • Botney MD
        • Bahadori L
        • Gold LI
        Vascular remodeling in primary pulmonary hypertension.
        Am J Pathol. 1994; 114: 286-295
        • Pertovaara L
        • Kaipainen A
        • Mustonen T
        • Orpana A
        • Ferrara N
        • Saksela O
        • et al.
        Vascular endothelial growth factor is induced in response to transforming growth factor-α in fibroblastic and epithelial cells.
        J Biol Chem. 1994; 269: 6271-6274
        • Humbert M
        • Monti G
        • Brenot F
        • Sitbon O
        • Portier A
        • Grangeot-Keros L
        • et al.
        Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.
        Am J Respir Crit Care Med. 1995; 151: 1628-1631
        • Stavri GT
        • Hong Y
        • Zachary IC
        • Breier G
        • Baskerville PA
        • Yla-Herttuala S
        • et al.
        Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells.
        FEBS Lett. 1995; 358: 311-315
        • Tuder RM
        • Wang J
        • Lee SD
        • Voelkel NF
        Vascular endothelial growth factor (VEGF) expression in normal and remodeled pulmonary arteries in severe pulmonary hypertension.
        Am J Respir Crit Care Med. 1997; 155 ([abstract]): A627
        • Barleon B
        • Sozzani S
        • Zhou D
        • Weich HA
        • Mantovani A
        • Marmé D
        Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.
        Blood. 1996; 87: 3336-3343
        • MacDermot J
        • Kelsey CR
        • Waddell KA
        • Richmond R
        • Knight RK
        • Cole PT
        • et al.
        Synthesis of leukotriene B4 and prostaniods by human alveolar macrophages: Analysis by gas chromatography/mass spectrophotometry.
        Prostaglandins. 1984; 27: 163-177
        • Lepley RA
        • Fitzpatrick FA
        5-lipoxygenase contains a functional Src homology 3-binding motif that interacts with the Src homology 3 domain of Grb2 and cytoskeletal proteins.
        J Biol Chem. 1994; 269: 24163-24168
        • Wright L
        • Tuder RM
        • Wang J
        • Cool CD
        • Lepley RA
        • Voelkel NF
        • et al.
        5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension.
        Am J Respir Crit Care Med. 1998; 157: 219-229
        • Wilson DW
        • Segall HJ
        • Pan LC
        • Dunston SK
        Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats.
        Microvasc Res. 1989; 38: 57-80
        • Hu L-M
        • Jones R
        Injury and remodeling of pulmonary veins by high oxygen.
        Am J Pathol. 1989; 134: 253-262
        • Ono S
        • Voelkel NF
        Inflammation and pulmonary hypertension during hypoxia.
        in: Ueda G Veda G Reeves JT Sekiguchi M High altitude medicine. Shinshu University Press, Matsumoto1992: 347-354
        • Herget J
        • Palecek F
        • Preclik P
        • Cermakova M
        • Vizek M
        • Petrovicka M
        • et al.
        Pulmonary hypertension induced by repeated pulmonary inflammation in the rat.
        J Appl Physiol. 1981; 51: 755-761
        • Meyrick B
        • Brigham KL
        Repeated Escherichia coli endotoxin-induced pulmonary inflammation causes chronic pulmonary hypertension in sheep structural and functional changes.
        Lab Invest. 1996; 55: 164-176
        • Resnick N
        • Collins T
        • Atkinson W
        • Bonthron DT
        • Dewey Jr, CF
        • et al.
        Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element.
        in: 2nd ed. Proc Natl Acad Sci USA. 90. 1993: 4593-4595
        • Das KC
        • Lewis-Molock Y
        • White CW
        Activation of NF-kappa B and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells.
        Am J Physiol. 1995; 269: L588-L602
        • Forsythe JA
        • Jiang B-H
        • Iyer NV
        • Agani F
        • Leung SW
        • Koos RD
        • et al.
        Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.
        Mol Cell Biol. 1996; 16: 4604-4613
        • Liu Y
        • Cox SR
        • Morita T
        • Kourembanas S
        Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer.
        Circ Res. 1995; 77: 638-643
      1. Stern DM. Hypoxia, inflammation and clotting. Thomas L Petty Aspen Lung Conference, Fortieth Annual Meeting. Chest (in press).

        • Voelkel NF
        • Tuder RM
        • Bridges J
        • Arend WP
        Interleukin- 1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
        Am J Respir Cell Mol Biol. 1994; 11: 664-675
        • Raines EW
        • Dower SK
        • Ross R
        Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA.
        Science. 1988; 243: 393-397
        • Li J
        • Perrella MA
        • Tsal JC
        • Yet SF
        • Hsieh CM
        • Yoshizumi M
        • et al.
        Induction of vascular endothelial growth factor gene expression by interleukin-lβ in rat aortic smooth muscle cells.
        J Biol Chem. 1995; 270: 308-312
        • Voelkel NF
        • Worthen SW
        • Reeves JT
        • Henson PM
        • Murphy RC
        Nonimmunological production of leukotrienes induced by platelet-activating factor.
        Science. 1982; 218: 286-288
        • Ono S
        • Westcott JY
        • Voelkel NF
        PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
        J Appl Physiol. 1992; 73: 1084-1092
        • Voelkel NF
        • Tuder RM
        • Wade K
        • Höper M
        • Lepley RA
        • Goulet JL
        • et al.
        Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
        J Clin Invest. 1996; 97: 2491-2498
        • Stenmark KR
        • Morganroth MC
        • Remigo LK
        • Voelkel NF
        • Murphy RC
        • Henson PM
        • et al.
        Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension.
        Am J Physiol. 1985; 248: H859-H866
        • Tuder RM
        • Flook BE
        • Voelkel NF
        Increased gene expression for VEGF and the VEGF receptors KDR/F1k and Fit in lungs exposed to acute or to chronic hypoxia.
        J Clin Invest. 1995; 95: 1798-1807
        • Tuder RM
        • Allard I
        • Voelkel NF
        Role of vascular endothelial growth factor in hypoxia and monocrotaline induced pulmonary hypertension.
        Circulation. 1996; 94: 1647
        • Ziche M
        • Morbidelli L
        • Choudhuri R
        • Zhang H-T
        • Donnini S
        • Granger HJ
        • et al.
        Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.
        J Clin Invest. 1997; 99: 2625-2634
        • Morrell NW
        • Grieshaber SS
        • Danilov SM
        • Majack RA
        • Stenmark KR
        Developmental regulation of angiotensin converting enzyme and angiotensin type 1 receptor in the rat pulmonary circulation.
        Am J Respir Cell Mol Biol. 1996; 14: 526-537
        • Morrell NW
        • Morris KG
        • Stenmark KR
        Role of angiotensinconverting enzyme and angiotensin II in development of hypoxic pulmonary hypertension.
        Am J Physiol. 1995; 269: H1186-H1194
        • Morrell NW
        • Atochina EN
        • Morris KG
        • Danilov SM
        • Stenmark KR
        Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.
        J Clin Invest. 1995; 96: 1823-1833
        • Levin ER
        Mechanisms of disease: Endothelins.
        N Engl J Med. 1995; 333: 356-363
        • Miyauchi T
        • Yorikane R
        • Sakai S
        • Sakurai T
        • Okada M
        • Nishikibe M
        • et al.
        Contribution of endogenous endothelin1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
        Circ Res. 1993; 73: 887-897
        • Ivy DD
        • Parker TA
        • Ziegler JW
        • Galan HL
        • Kinsella JP
        • Tuder RM
        • et al.
        Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.
        J Clin Invest. 1997; 99: 1179-1186
        • Perkett EA
        • Lyons RM
        • Moses HL
        • Brigham KL
        • Meyrick B
        Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension.
        J Clin Invest. 1990; 86: 1459-1464
        • Badesch DB
        • Lee PD
        • Parks WC
        • Stenmark KR
        Insulin-like growth factor I stimulates elastin synthesis by bovine pulmonary arterial smooth muscle cells.
        Biochem Biophys Res Commun. 1989; 160: 382-387
        • Widimsky J
        • Riedel M
        • Stanek V
        Central haemodynamics during exercise in patients with restrictive pulmonary disease.
        Bull Eur Physiopath Resp. 1977; 13: 369-379
        • Andoh Y
        • Shimura S
        • Aikawa T
        • Sasaki H
        • Takishima T
        Perivascular fibrosis of muscular pulmonary arteries in chronic obstructive pulmonary disease.
        Chest. 1992; 102: 1645-1649